PMID- 16141241 OWN - NLM STAT- MEDLINE DCOM- 20080805 LR - 20050922 IS - 0953-8178 (Print) IS - 0953-8178 (Linking) VI - 17 IP - 10 DP - 2005 Oct TI - IL-4 is more effective than IL-13 for in vitro differentiation of dendritic cells from peripheral blood mononuclear cells. PG - 1337-46 AB - Dendritic cells (DCs) are the most potent professional antigen-presenting cells which can activate T cells to induce the primary immune response. For clinical studies, DCs are often differentiated in vitro from peripheral blood mononuclear cells (PBMCs) through treatment with granulocyte macrophage colony-stimulating factor (GM-CSF) and IL-4. However, IL-13, a cytokine closely related to IL-4, has also been reported to induce differentiation equally or more efficiently when used with GM-CSF. For the present study, we compared the DC characteristics exhibited by iDCs and LPS-matured DCs differentiated from PBMCs using GM-CSF and IL-4 or IL-13. Physical characteristics examined include cellular morphology and surface phenotype. Functional traits investigated include FITC-dextran uptake, IL-10 and IL-12 production, allostimulation and cytokine production by stimulated T cells and antigen-specific T cell stimulation. Compared with IL-13-derived DCs, IL-4 treatment yielded more differentiated DCs, with extensive dendrites and higher expression of DC-SIGN, DEC-205, CD86 and HLA-DR. In addition, IL-4 DCs were more efficient at inducing allogeneic T cell proliferation and immature IL-4 DCs had higher endocytic activity at low FITC-dextran concentrations (1 microg ml(-1)). Although IL-13 was capable of generating DCs from PBMCs, it was not as effective as IL-4 in generating DC phenotype and functionality. Thus, the use of GM-CSF and IL-4 is the more efficient treatment for inducing DC differentiation from PBMCs. FAU - Ahn, Justin S AU - Ahn JS AD - Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2S2, Canada. FAU - Agrawal, Babita AU - Agrawal B LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20050902 PL - England TA - Int Immunol JT - International immunology JID - 8916182 RN - 0 (Antigens) RN - 0 (HLA-DR Antigens) RN - 0 (Interleukin-13) RN - 207137-56-2 (Interleukin-4) SB - IM MH - Antigens/blood MH - Cell Culture Techniques MH - Cell Differentiation/*immunology MH - Cell Proliferation MH - Cells, Cultured MH - Dendritic Cells/*cytology/immunology MH - Endocytosis/immunology MH - HLA-DR Antigens/biosynthesis/blood MH - Humans MH - Interleukin-13/*blood MH - Interleukin-4/*blood MH - Leukocytes, Mononuclear/*cytology/immunology MH - T-Lymphocytes/immunology EDAT- 2005/09/06 09:00 MHDA- 2008/08/06 09:00 CRDT- 2005/09/06 09:00 PHST- 2005/09/06 09:00 [pubmed] PHST- 2008/08/06 09:00 [medline] PHST- 2005/09/06 09:00 [entrez] AID - dxh312 [pii] AID - 10.1093/intimm/dxh312 [doi] PST - ppublish SO - Int Immunol. 2005 Oct;17(10):1337-46. doi: 10.1093/intimm/dxh312. Epub 2005 Sep 2.